Ralph Henry, PhD

Dr. Henry is a biochemist with nearly 20 years experience working with drug substance and drug product manufacturers to ensure product safety, consistency, and stability for pre-clinical through Phase 2 human trials. His collaborative work at Kuria Therapeutics provides oversight of GMP-compliant manufacturing and formulation activities for the company’s ophthalmic products.